I’m speaking tomorrow at the Berkeley AAII meeting, then Tuesday at TradeTech West in SF. If you’re at either, come say hello!
—-
I enjoy getting constructive criticism, and hecklers don’t bother me, but at least have the dignity to read the book before you post a review! Examples here (Louis and Rodi Williams reviews).
Although this is definitely my favorite 1 star review!
—-
—-
Seems like a trading strategy to me.
—-
—-
Well, this is certainly a contrarian position: We need more debt, not less.
—-
The 50 Best Things to Eat in the World. I’ve had 0. Although I’m still waiting for someone to take me up on Alinea on my upcoming Chicago trip…
—-
—-
Hookworm as a cure for asthma?
—-
Gene Therapy Cures Color-Blind Monkeys.
—-
—-
Some notes from Pabrai’s annual investor meeting. Concentration works both ways!!
—-
POTENTIALLY interesting, let’s see what other funds they come out with. 130/30, meh.
I wanna know who the genius was that thought that 1 star review of the Ivy Portfolio was helpful!
“Yes, Please”.
The New York Times article about letting everyone into hedge funds probably won't happen anytime soon, now that they're back into making money. Lobbyists have a way of defering shared access to things like health care and money. LOL.
QAI fund manager was on Bloomberg this afternoon and made his case. It's up 8% since inception I think.
I wanna know who the genius was that thought that 1 star review of the Ivy Portfolio was helpful!
“Yes, Please”.
The New York Times article about letting everyone into hedge funds probably won't happen anytime soon, now that they're back into making money. Lobbyists have a way of defering shared access to things like health care and money. LOL.
QAI fund manager was on Bloomberg this afternoon and made his case. It's up 8% since inception I think.